Endowment Wealth Management, Inc. - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endowment Wealth Management, Inc. ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$285,728
-10.6%
97,5180.0%0.26%
-12.3%
Q2 2023$319,481
+7.0%
97,518
+0.9%
0.29%
-2.3%
Q1 2023$298,550
+46.4%
96,6180.0%0.30%
+33.9%
Q4 2022$203,864
-35.3%
96,6180.0%0.22%
-41.4%
Q3 2022$315,000
+1.6%
96,6180.0%0.38%
+2.4%
Q2 2022$310,000
-54.5%
96,6180.0%0.37%
-48.0%
Q1 2022$682,000
-2.6%
96,6180.0%0.72%
+1.3%
Q4 2021$700,00096,6180.71%
Other shareholders
HUMACYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders